Why Lexeo Therapeutics Inc. (NASDAQ:LXEO) Stock down -0.99% in Last Week?
Robert W. Baird raised the price target for the Lexeo Therapeutics Inc. (NASDAQ:LXEO) stock to “an Outperform”. The rating was released on June 13, 2024, according to finviz. The research report from Stifel has initiated the stock to Buy, with a price target set at $20. The stock was initiated by RBC Capital Mkts, who […]
There Is Nothing Like Lexeo Therapeutics Inc. (LXEO) Stock
Robert W. Baird raised the price target for the Lexeo Therapeutics Inc. (NASDAQ:LXEO) stock to “an Outperform”. The rating was released on June 13, 2024, according to finviz. The research report from Stifel has initiated the stock to Buy, with a price target set at $20. The stock was initiated by RBC Capital Mkts, who […]
Is this a gain, a loss, or a throwaway? Lexeo Therapeutics Inc. (LXEO) Stock
Robert W. Baird raised the price target for the Lexeo Therapeutics Inc. (NASDAQ:LXEO) stock to “an Outperform”. The rating was released on June 13, 2024, according to finviz. The research report from Stifel has initiated the stock to Buy, with a price target set at $20. The stock was initiated by RBC Capital Mkts, who […]
What does Lexeo Therapeutics Inc. (LXEO) Stock have to offer?
Stifel raised the price target for the Lexeo Therapeutics Inc. (NASDAQ:LXEO) stock to “a Buy”. The rating was released on November 28, 2023, according to finviz. The research report from Leerink Partners has initiated the stock to Outperform, with a price target set at $19. The stock was initiated by JP Morgan, who disclosed in […]
